Analysis

Relationships with the drug industry: Focus on better information

BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b252 (Published 04 February 2009) Cite this as: BMJ 2009;338:b252
  1. Richard Tiner, medical director
  1. 1Association of the British Pharmaceutical Industry, London SW1A 2DY
  1. rtiner{at}abpi.org.uk

    The relationship between the drug industry, academia, healthcare professionals, and patients has reached an all time low and few doubt that it is in the interests of all parties to improve it. A recent report from the Royal College of Physicians attempts to define a path towards achieving a more productive relationship. Here we set out five contrasting views on what the ideal relationship between industry and prescribers and patients should be and what steps need to be taken to achieve it (doi:10.1136/bmj.b222, doi:10.1136/bmj.b211, doi:10.1136/bmj.b252, doi:10.1136/bmj.b232)

    The primary role of the research based drug industry is to discover, develop, license, and market innovative medicines to prevent, treat, or cure disease. This role has a prime benefit for patients but also …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe